Reduction of doxorubicin resistance in P-glycoprotein overexpressing cells by hybrid cell-penetrating and drug-binding peptide

By Zheng Zhaohua   Aojula Harmesh   Clarke David  

Journal of Drug Targeting, Vol. 18, Iss. 6, 2010-07 ,pp. : 477-487

Informa Healthcare

Access to resources Recommend Favorite

P-Glycoprotein - Implications of Metabolism of Neoplastic Cells and Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 6, 2005-09 ,pp. : 457-468

Bentham Science Publishers

Access to resources Recommend Favorite

Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers

By Zastre J.   Jackson J.   Bajwa M.   Liggins R.   Iqbal F.   Burt H.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 54, Iss. 3, 2002-11 ,pp. : 299-309

Elsevier

Access to resources Recommend Favorite

Inhibition of P-glycoprotein in tumour cells

By LeBlanc G.A.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 121-123

Informa Healthcare

Access to resources Recommend Favorite

Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest

By Kim Won  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1311-1318

Springer Publishing Company

Access to resources Recommend Favorite